Silencing of long noncoding RNA PVT1 inhibits podocyte damage and apoptosis in diabetic nephropathy by upregulating FOXA1

Diabetic kidney disease: Improving treatment by targeting an RNA molecule Targeting an RNA molecule responsible for disrupting metabolic protein levels in diabetic kidney disease may improve treatment. Diabetic nephropathy (DN) can affect people with type I or type II diabetes, and results in functi...

Full description

Bibliographic Details
Main Authors: Dong-Wei Liu, Jia-Hui Zhang, Feng-Xun Liu, Xu-Tong Wang, Shao-Kang Pan, Deng-Ke Jiang, Zi-Hao Zhao, Zhang-Suo Liu
Format: Article
Language:English
Published: Nature Publishing Group 2019-08-01
Series:Experimental and Molecular Medicine
Online Access:https://doi.org/10.1038/s12276-019-0259-6